baytril 50 mg/ml inj. sol. i.m./s.c./i.v. vial
bayer animal health gmbh - enrofloxacin 50 mg/ml - solution for injection - 50 mg/ml - enrofloxacin 50 mg/ml - enrofloxacin - cattle; pig; sheep; goat; dog; cat
enrox classic 5 % 50 mg/ml inj. sol. i.v./s.c./i.m. vial
krka d.d. novo mesto d.d. - enrofloxacin 50 mg/ml - solution for injection - 50 mg/ml - enrofloxacin 50 mg/ml - enrofloxacin - cattle; pig
fenoflox 50 mg/ml inj. sol. i.m./s.c./i.v. vial
chanelle pharm. man. ltd. - enrofloxacin 50 mg/ml - solution for injection - 50 mg/ml - enrofloxacin 50 mg/ml - enrofloxacin - cattle; dog; cat; pig
floxadil 50 mg/ml inj. sol. i.m./i.v./s.c. vial
emdoka s.p.r.l.-b.v.b.a. - enrofloxacin 50 mg/ml - solution for injection - 50 mg/ml - enrofloxacin 50 mg/ml - enrofloxacin - cattle; pig
baytril 5% 50mg/ml solution for injection
bayer philippines inc.; distributor: bayer philippines inc. - enrofloxacin 50mg/ml solution for injection - solution for injection - 50mg/ml
enrofloxacin flavored- enrofloxacin tablet, chewable
putney, inc. - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin 22.7 mg - enrofloxacin flavored tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. enrofloxacin flavored tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.
fenoflox 50 mg/ml solution for injection for cattle, pigs, dogs and cats
chanelle pharmaceuticals manufacturing limited - enrofloxacin - solution for injection - 50 milligram(s)/millilitre - enrofloxacin - bovine, canine, feline, porcine - antibacterial
floxibac 50 mg/ml solution for injection for cattle, pigs, dogs and cats
chanelle pharmaceuticals manufacturing limited - enrofloxacin - solution for injection - 50 milligram(s)/millilitre - enrofloxacin - bovine, canine, feline, porcine - antibacterial
enrotron 50 mg/ml solution for injection for cattle, sheep, goats, pigs, dogs and cats
animedica gmbh - enrofloxacin - solution for injection - 50 milligram(s)/millilitre - enrofloxacin
enrofloxacin flavored- enrofloxacin tablet
felix pharmaceuticals private limited - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin flavored tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. enrofloxacin flavored tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.